MTPH.L Share News (MTPH)

Midatech Pharma 2017 Loss Narrows On Costs And Impairments Fall

LONDON (Alliance News) - Midatech Pharma PLC said Monday its 2017 loss narrowed on lower costs and reduced impairments as its approaches 2018 with a number of key "inflection" points for

Midatech Pharma CEO Phillips To Step Down, COO Cook Steps Up

LONDON (Alliance News) - Pharmaceutical firm Midatech Pharma PLC said Thursday its Chief Executive Jim Phillips will leave the company after five years at the who is departing

Midatech Pharma receives upfront access fee

(ShareCast News) - International speciality pharmaceutical company Midatech Pharma said it has received an upfront technology access fee and option payment of £450,000. This was under the terms of the exclusive licence granted to Emergex Vaccines Ltd. This licence covered the use of Midatech's prop

Midatech Pharma chooses MTR104 for liver cancer treatment

(ShareCast News) - International speciality pharmaceutical company Midatech Pharma has selected its candidate compound MTR104 to take into a formal IND-enabling programme during 2017. This would be followed by human studies planned for 2018, the company said. "The programme is focused on advanced l

BROKER RATINGS SUMMARY: HSBC Raises IAG To Hold From Reduce

Midatech To Raise GBP14 Million Via Placing And Open Offer (ALLISS)

Midatech Says Trials Of Drug Using Its Gold Nanoparticles Commence

Midatech Pharma's revenues increases due to US sales

(ShareCast News) - Midatech Pharma's half-year revenues increased significantly, with management sounding an optimistic note regarding the potential of the company´s research and development programmes. For the six months ended 30 June, revenue increased significantly to £3.8m from £320,000 in the s

Midatech-Cardiff University Collaboration Gets Diabetes Grant

Midatech Pharma Issues Final Shares To Settle Q Chip Acquisition (ALLISS)

Midatech Signals Further Focus On "Better Suited" Oncology Treatments

Midatech Pharma Trading Ahead Of Expectations On Strong Revenue Growth

Midatech Pharma Gets Positive Data From Q-Octreotide Trial

Midatech Pharma Sees Positive Dosing Data In Uveitis Programme

Midatech Loss Widens On Acquisition Costs, But Revenue Surges